- Home
- ATLX vs IMMX Comparison
ATLX vs IMMX Comparison
Compare ATLX & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLX
- IMMX
- Stock Information
- Founded
- ATLX 2011
- IMMX 2014
- Country
- ATLX Brazil
- IMMX United States
- Employees
- ATLX N/A
- IMMX N/A
- Industry
- ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- ATLX Industrials
- IMMX Health Care
- Exchange
- ATLX Nasdaq
- IMMX Nasdaq
- Market Cap
- ATLX 68.5M
- IMMX 61.1M
- IPO Year
- ATLX N/A
- IMMX 2021
- Fundamental
- Price
- ATLX $4.47
- IMMX $3.02
- Analyst Decision
- ATLX Strong Buy
- IMMX Strong Buy
- Analyst Count
- ATLX 2
- IMMX 1
- Target Price
- ATLX $22.25
- IMMX $7.00
- AVG Volume (30 Days)
- ATLX 301.5K
- IMMX 169.1K
- Earning Date
- ATLX 08-08-2025
- IMMX 08-11-2025
- Dividend Yield
- ATLX N/A
- IMMX N/A
- EPS Growth
- ATLX N/A
- IMMX N/A
- EPS
- ATLX N/A
- IMMX N/A
- Revenue
- ATLX $587,122.00
- IMMX N/A
- Revenue This Year
- ATLX $19,668.81
- IMMX N/A
- Revenue Next Year
- ATLX $43.15
- IMMX N/A
- P/E Ratio
- ATLX N/A
- IMMX N/A
- Revenue Growth
- ATLX 214.46
- IMMX N/A
- 52 Week Low
- ATLX $3.54
- IMMX $1.26
- 52 Week High
- ATLX $13.70
- IMMX $3.12
- Technical
- Relative Strength Index (RSI)
- ATLX 66.08
- IMMX 65.49
- Support Level
- ATLX $3.80
- IMMX $2.61
- Resistance Level
- ATLX $4.25
- IMMX $3.12
- Average True Range (ATR)
- ATLX 0.25
- IMMX 0.19
- MACD
- ATLX 0.08
- IMMX 0.04
- Stochastic Oscillator
- ATLX 100.00
- IMMX 82.24
About ATLX Atlas Lithium Corporation
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.